Sandrine Silvente-Poirot

7PUBLICATIONS
19CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 31, 2026
The Phospholipid Bis(monoacylglycero)Phosphate Confers Antitumour Immunogenicity to Exosomes Secreted by Dendrogenin A, Which Activates Its Biosynthesis in Tumour Cells.

Julio Buñay, Michel Record, Philippe de Medina

|Sep 05, 2022
Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes.

Philippe de Medina, Julio Bunay, Marc Poirot

|Apr 12, 2022
Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles.

Michel Record, Mehdi Attia, Kevin Carayon

|Mar 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.

Anne Montfort, Florie Bertrand, Julia Rochotte

|Jul 23, 2020
The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.

Philippe de Medina, Khadijetou Diallo, Emilie Huc-Claustre

|Aug 19, 2018
The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer.

Sandrine Silvente-Poirot, Florence Dalenc, Marc Poirot

Pageof 2

Frequent Collaborators

6 joint publications

Marc Poirot

3 joint publications

Philippe de Medina

3 joint publications

Julio Bunay

3 joint publications

Michel Record